Cargando…
Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the third leading cause of cancer-related death. sorafenib is used as a standard therapy to treat HCC. mesenchymal stromal cells (MSCs) have also been used to suppress HCC. Here we investigate the development of a xeno...
Autores principales: | Hajighasemlou, Saieh, Pakzad, Saeedreza, Ai, Jafar, Muhammadnejad, Samad, Mirmoghtadaei, Milad, Hosseinzadeh, Faezeh, Gharibzadeh, Safoora, Kamali, Amir, Ahmadi, Akbar, Verdi, Javad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103601/ https://www.ncbi.nlm.nih.gov/pubmed/29936790 http://dx.doi.org/10.22034/APJCP.2018.19.6.1627 |
Ejemplares similares
-
Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC
por: Hajighasemlou, Saieh, et al.
Publicado: (2020) -
Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model
por: Hajighasemlou, Saieh, et al.
Publicado: (2022) -
Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells
por: Seyhoun, Iman, et al.
Publicado: (2019) -
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2018) -
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2019)